Qube Research & Technologies LTD Regeneron Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 151,969 shares of REGN stock, worth $102 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

151,969

Previous 193,948 21.64%

Holding current value

$102 Million

Previous $204 Million 21.63%

% of portfolio

0.24%

Previous 0.33%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $43 Million - $50.4 Million	-41,979 Reduced 21.64%	151,969 $160 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $33.6 Million - $40.8 Million	38,100 Added 24.45%	193,948 $204 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $14 Million - $15.4 Million	-15,516 Reduced 9.05%	155,848 $150 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $128 Million - $146 Million	165,621 Added 2883.88%	171,364 $151 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $3.98 Million - $4.85 Million	5,743 New	5,743 $4.73 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $69.5 Million - $84.5 Million	-102,160 Reduced 95.76%	4,519 $3.71 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $69.9 Million - $75.9 Million	98,996 Added 1288.51%	106,679 $77 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $43.1 Million - $54.4 Million	-75,067 Reduced 90.72%	7,683 $5.29 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $40.1 Million - $54 Million	73,120 Added 759.29%	82,750 $48.9 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $6.56 Million - $7.7 Million	-11,030 Reduced 53.39%	9,630 $6.73 Million
Q4 2021 Feb 01, 2022	SELL	$543.48 - $670.97 $8.69 Million - $10.7 Million	-15,985 Reduced 43.62%	20,660 $13 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $21 Million - $25 Million	36,645 New	36,645 $22.2 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $11.9 Million - $14.6 Million	-26,622 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $1.51 Million - $1.92 Million	3,152 Added 13.43%	26,622 $12.9 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $12.8 Million - $15.4 Million	23,470 New	23,470 $13.1 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $1.58 Million - $1.84 Million	-5,766 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$299.6 - $414.82 $1.73 Million - $2.39 Million	5,766 New	5,766 $1.81 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $925,519 - $1.11 Million	-2,756 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $967,741 - $1.13 Million	2,756 New	2,756 $1.11 Million

Others Institutions Holding REGN

# of Institutions

1,500

Shares Held

83M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Regeneron Pharmaceuticals, Inc. Transaction History